Khan, O A <br/><br/>
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours.  [electronic resource] 

 -  British journal of cancer  Mar 2011 
 - 750-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2011.8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Dacarbazine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Neutropenia--chemically induced<br/>Phthalazines--administration & dosage<br/>Piperazines--administration & dosage<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Thrombocytopenia--chemically induced